In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.

@article{Elliott2006InVD,
  title={In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.},
  author={Eugenne Elliott and Adrian John Brink and Johan van Greune and Zia Els and Neil Woodford and Jane Turton and Marina Warner and David Martin Livermore},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2006},
  volume={42 11},
  pages={e95-8}
}
Four sequential extended-spectrum beta -lactamase-producing isolates of Klebsiella pneumoniae were obtained from a patient after treatment with ertapenem and cultured. The first and fourth isolates were susceptible to ertapenem, whereas the second and third were resistant. All 4 isolates belonged to the same strain and produced a group 1 CTX-M enzyme; additionally, the resistant isolates had lost a porin. 

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 55 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 10 references

Ertapenem for the treatment of extended spectrum beta-lactamase (ESBL) producing organisms [abstract K-1591

  • LS Munoz, M Hovsepian, DR Snydman
  • Program and abstracts of the 44th Interscience…
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…